Prevalence of periodontitis in a population of patients on dialysis in Colombia.

The aim of this study is to establish the prevalence of Chronic Periodontitis (CP) in patients with Chronic Kidney Disease (CKD) and to ascertain its relationship with several factors or indicators of micro inflammation. One hundred and thirty-jive CKD patients on dialysis treatment were included. Biochemical parameters, clinical attachment level and pocket depth were recorded according of the American Academy of Periodontology and the CDC (CDC-AAP). Gingivitis and CP were recorded based on the biofilm-gingival interface (BGI) periodontal diseases classification. The rate of non-response to the survey was 10 percent. A total 2,636 teeth in 135 patients were examined, of whom 52.5% were males. Average age was 55.7 years (SD ± 1.32); 41.4% had a smoking history; 78/135 patients were on hemodialysis and 57/135 on peritoneal dialysis; 55.5% had been on dialysis for more than three years. Prevalence of gingivitis and periodontitis was 14.8%, 95% CI (9.7-21.9) and 82.2%, 95% CI (74.7 - 87.8), respectively; according to the BGI Index. Severity of CP was: No periodontitis, 14.0% 95% CI (9.1 - 21.1); mild, 11.1% 95% CI (6.7 -17.7); moderate, 28.8% 95% CI (21.7- 37.1); and severe, 45.9% 95% CI (31.6-54.47). Peritoneal dialysis and time on dialysis > 3 years increase the chance of having periodontitis, OR 11.0 95% CI (2.2-53.8) and OR 7.6 95% CI (1.1-50.2), respectively. In view of the high prevalence of CP in this population, programs designed to ensure better periodontal and gingival care in the population on dialysis need to be established.

El objetivo de este estudio fue establecer la prevalencia de Periodontitis Crónica (PC) en pacientes con enfermedad renal crónica (ERC) en diálisis y determinar la relación de su presencia con algunos indicadores de micro inflamación. Un total de 135 pacientes con ERC en terapia dialítica fueron incluidos en este estudio. Se evaluaron parámetros bioquímicos, nivel de inserción clínica (NIC) y profundidad de sondaje (PS), de acuerdo con la Asociación Americana de Periodoncia y el CDC de Atlanta (CDC-AAP). También fue evaluada, la gingivitis y la PC de acuerdo con la clasificación interface biopelicula-encia (BGI). La tasa de no respuesta a la encuesta fue del 10%. Un total de 2636 dientes en 135 pacientes fueron evaluados, (52.5% hombres, edad promedio 55.7 ± 1.32), 56% con antecedente de tabaquismo. 78/135 en hemodiálisis y 57/135 en diálisis peritoneal, el 55.5 % con un tiempo en diálisis mayor a tres años. La prevalencia de gingivitis por la clasificación BGI fue del 14.8% IC 95% (9.7 - 21.9) y de periodontitis 82.2% IC 95% (74.7 - 87.8). La severidad de la PC fue: sin periodontitis 14.0% 95% IC (9.1 - 21.1); leve 11.1% 95% IC (6.7 - 17.7); moderada 28.8% 95% IC (21.7 - 37.1) y severa 45.9% 95% IC (31.6-54.47) La diálisis peritoneal y el tiempo en diálisis aumentaron la chance de tener PC: OR 11.0 95% IC (2.2-53.8) y OR 7.6 95% CI (1.1-50.2) respectivamente. Por la alta prevalencia de PC en esta población, es necesario establecer programas para asegurar el cuidado de la salud periodontal en esta población en diálisis.

La plausibilidad biológica entre la periodontitis crónica y el infarto cerebral isquémico / Biological plausibility of the relationship between chronic periodontitis and ischemic stroke

Introducción: Las bolsas periodontales reales constituyen un reservorio importante de bacterias gramnegativas que pueden por diversas vías ejercer influencia en sitios distantes, lo cual provoca alteraciones sistémicas como las enfermedades derivadas de la aterosclerosis. Objetivo: Explicar los fundamentos teóricos que sustentan la propuesta de la periodontitis crónica como un factor de riesgo para el infarto cerebral isquémico. Contenido: 1) La aterosclerosis y las enfermedades cerebrovasculares, generalidades de su patogenia. 2) La microbiota periodontal, fundamentos de su asociación con la aterosclerosis y la enfermedad cerebrovascular isquémica. Exposición del tema: La inflamación es un elemento de vital importancia en todas las fases del proceso aterosclerótico, tanto en su inicio, progresión, como en sus complicaciones. La naturaleza de las enfermedades periodontales inmunoinflamatorias crónicas y la infección subgingival anaerobia asociada a ellas, representa una injuria metastásica que produce y disemina mediadores inflamatorios favorecedores de la ateroesclerosis, participando en la colonización, y ruptura de placas ateromatosas; procesos implicados en la patogenia del infarto cerebral isquémico. Consideraciones finales: El mayor conocimiento de la relación riesgosa entre periodontitis crónica e infarto cerebral isquémico, permitiría una utilización racional de estrategias de prevención y tratamiento de la enfermedad cerebrovascular, basadas en la detección de procesos inflamatorios como las periodontopatías crónicas(AU)

Introduction: True periodontal pockets are an important reservoir of gram-negative bacteria which may exert an influence on distant sites in a variety of manners, bringing about systemic alterations such as diseases derived from atherosclerosis. Objective: Explain the theoretical foundations supporting the proposal of chronic periodontitis as a risk factor for ischemic stroke. Content: 1) Atherosclerosis and cerebrovascular disease, an overview of their pathogenesis. 2) The periodontal microbiota, bases for its association with atherosclerosis and ischemic stroke Topic presentation: Inflammation is an element of vital importance in all the stages of the atherosclerotic process, be it its onset, progress or complications. By their nature, chronic immunoinflammatory periodontal diseases and the associated anaerobic subgingival infection, constitute a metastatic injury that produces and spreads inflammatory mediators leading to atherosclerosis and participating in the colonization and rupture of atheromatous plaques, which are processes involved in the pathogenesis of ischemic stroke. Final considerations: Better knowledge about the risk relationship between chronic periodontitis and ischemic stroke would allow a rational use of strategies for the prevention and treatment of cerebrovascular disease based on detection of inflammatory processes such as chronic periodontal conditions(AU)

Relationship between human immunodeficiency virus (HIV-1) infection and chronic periodontitis.

INTRODUCTION: Current studies show that, even in the era of antiretroviral therapies, HIV-1 infection is associated with more severe and frequent refractory chronic periodontitis. Areas covered: This review, based on a systematic analysis of the literature, intends to provide an update on factors that may be involved in the pathogenesis of periodontal disease in HIV-1-infected patients, including local immunosuppression, oral microbial factors, systemic inflammation, salivary markers, and the role of gingival tissue as a possible reservoir of HIV-1. Expert commentary: The therapeutic revolution of ART made HIV-1 infection a chronic controllable disease, reduced HIV-1 mortality rate, restored at least partially the immune response and dramatically increased life expectancy of HIV-1-infected patients. Despite all these positive aspects, chronic periodontitis assumes an important role in the HIV-1 infection status for activating systemic inflammation favoring viral replication and influencing HIV-1 status, and also acting as a possible reservoir of HIV-1. All these issues still need to be clarified and validated, but have important clinical implications that certainly will benefit the diagnosis and management of chronic periodontitis in HIV-1-infected patients, and also contributes to HIV-1 eradication.

The combined and individual impact of diabetes and smoking on key subgingival periodontal pathogens in patients with chronic periodontitis.

BACKGROUND AND OBJECTIVE: Comprehension of the similarities and differences in the composition of the subgingival microbiota of patients with diabetes mellitus (DM), smokers or smokers with DM is an important step in developing therapies specific for these groups at risk for periodontitis. Therefore, the aim of this study was to compare the combined and individual effects of DM and smoking on the levels and prevalence of key subgingival periodontal pathogens in patients with chronic periodontitis. MATERIAL AND METHODS: One hundred patients with generalized chronic periodontitis were allocated into one of the following groups: DM (n = 25, non-smokers with type 2 DM); S (n = 25, non-diabetic smokers); SDM (n = 25, smokers with type 2 DM); and control (n = 25, non-diabetic non-smokers). Two subgingival biofilm samples from healthy sites (probing depth and clinical attachment level ≤3 mm and no bleeding) and 2 from diseased sites (probing depth and clinical attachment level ≥5 mm and bleeding on probing) were analyzed by quantitative polymerase chain reaction for Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola, Eubacterium nodatum, Parvimonas micra, Fusobacterium nucleatum ssp. and Prevotella intermedia. RESULTS: There were no differences among groups in the mean counts of the bacterial species studied, considering all sampled sites (healthy plus diseased sites). There were also no differences among groups regarding the prevalence of any bacteria species in healthy and diseased sites (P > .05). The mean P. micra count was significantly higher in the healthy sites of both smoking groups, than in those of the control group (P < .05). CONCLUSION: The subgingival levels and prevalence of the bacterial species studied are not significantly different in subjects with chronic periodontitis presenting DM, smokers or smokers with DM. In addition, DM and smoking, jointly and individually, do not considerably affect the subgingival levels of target periodontal pathogens in patients with chronic periodontitis.

Prótese total imediata em paciente com periodontite crônica associada ao tabagismo ­ relato de caso / Immediate total prosthesis in a patient with chronic periodontitis associated with smoking ­ case report

O tabagismo é uma prática que traz muitos malefícios aos usuários, tanto à saúde sistêmica quanto à oral. O efeito mais comum observado na cavidade oral é a periodontite, podendo culminar na cronificação da doença, consequentemente, levando à perda dos elementos dentários, fazendo-se necessária a intervenção protética. Este trabalho tem como objetivo relatar o tratamento reabilitador por meio de prótese total imediata em paciente portador de periodontite crônica com extensa perda óssea associada ao tabagismo. O mesmo foi diagnosticado com periodontite crônica severa associada ao tabagismo e o tratamento proposto foi a extração de todos os elementos superiores com enfoque para a reabilitação em prótese total imediata superior e confecção de prótese parcial removível inferior. Concluiu-se que o tratamento eleito proporcionou uma reabilitação satisfatória tanto no aspecto clínico quanto emocional do paciente, pois restabeleceu a capacidade mastigatória adequada, trouxe melhora na fonética, conferiu aspecto de cavidade oral saudável e, principalmente, bem-estar estético e social (AU).

Smoking is a practice that brings much harm to its users, both to systemic and oral health. The most common effect observed in the oral cavity is periodontitis, which can culminate in the chronification of the disease, consequently leading to loss of dental elements, making prosthetic intervention necessary. This work aims to report rehabilitation treatment through immediate total prosthesis in patient with chronic periodontitis with extensive bone loss associated with smoking. This patient was diagnosed with severe chronic periodontitis associated with smoking and the proposed treatment was the extraction of all the superior elements with focus on the rehabilitation in the immediate superior total prosthesis and the manufacture of lower removable partial denture. It was concluded that the elected treatment provided a satisfactory rehabilitation for both patient clinical and emotional aspects, as it reestablished adequate masticatory capacity, improved phonetics, conferred a healthy oral cavity aspect, essential aesthetic, and mainly, aesthetic and social well-being (AU).

Gingival crevicular fluid oxidative stress level in patients with periodontal disease and hyperlipidemia.

This study aimed to assess the impact of hyperlipidemia on healthy and diseased periodontal tissue by evaluating oxidative stress biomarkers in gingival crevicular fluid (GCF). Clinical periodontal parameters and blood serum lipid, GCF malondialdehyde (MDA), protein carbonyl (PC), and total antioxidant capacity (TAOC) levels were evaluated in six age and sex-matched groups (n = 15 each) of normolipidemic and hyperlipidemic individuals as follows: normolipidemic + periodontally healthy (H), normolipidemic + gingivitis (G), normolipidemic + chronic periodontitis (CP), hyperlipidemic + periodontally healthy (HH), hyperlipidemic + gingivitis (HG), and hyperlipidemic + CP (HCP). GCF MDA, and PC levels varied among groups, with patients with periodontitis having the highest MDA and PC levels [CP > G > H (p < 0.01) and HCP > HG > HH (p < 0.01)] and the lowest TAOC levels [CP < G < H (p < 0.01) and HCP < HG < HH (p < 0.01)]. Furthermore, paired comparisons showed MDA and PC levels to be higher and TAOC levels to be lower in HCP compared with NCP (p < 0.01). In patients with hyperlipidemia, GCF, MDA, and PC levels positively correlated with clinical assessments and serum triglycerides (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL) levels and negatively correlated with serum high-density lipoprotein cholesterol (HDL) levels, whereas GCF TAOC levels negatively correlated with clinical assessments and serum TG, TC, and LDL levels, but positively correlated with serum HDL levels (p < 0.01). In normolipidemic patients, GCF, MDA, and PC levels positively correlated with clinical assessments and serum TG levels and negatively correlated with serum HDL levels, whereas GCF TAOC levels negatively correlated with clinical assessments and serum TG levels and positively correlated with serum HDL levels (p < 0.01). In conclusion, abnormal serum lipid subfractions could be considered a risk factor for enhancing oxidative stress in GCF in the presence of periodontal disease.

Role of 1% alendronate gel as adjunct to mechanical therapy in the treatment of chronic periodontitis among smokers.

OBJECTIVE: Alendronate (ALN) inhibits osteoclastic bone resorption and triggers osteostimulative properties both in vivo and in vitro, as shown by increase in matrix formation. This study aimed to explore the efficacy of 1% ALN gel as local drug delivery (LDD) in adjunct to scaling and root planing (SRP) for the treatment of chronic periodontitis among smokers. MATERIAL AND METHODS: 75 intrabony defects were treated in 46 male smokers either with 1% ALN gel or placebo gel. ALN gel was prepared by adding ALN into carbopol-distilled water mixture. Clinical parameters [modified sulcus bleeding index, plaque index, probing depth (PD), and periodontal attachment level (PAL)] were recorded at baseline, at 2 months, and at 6 months, while radiographic parameters were recorded at baseline and at 6 months. Defect fill at baseline and at 6 months was calculated on standardized radiographs by using the image analysis software. RESULTS: Mean PD reduction and mean PAL gain were found to be greater in the ALN group than in the placebo group, both at 2 and 6 months. Furthermore, a significantly greater mean percentage of bone fill was found in the ALN group (41.05±11.40%) compared to the placebo group (2.5±0.93%). CONCLUSIONS: The results of this study showed 1% ALN stimulated a significant increase in PD reduction, PAL gain, and an improved bone fill compared to placebo gel in chronic periodontitis among smokers. Thus, 1% ALN, along with SRP, is effective in the treatment of chronic periodontitis in smokers.

Role of 1% alendronate gel as adjunct to mechanical therapy in the treatment of chronic periodontitis among smokers

Abstract Objective Alendronate (ALN) inhibits osteoclastic bone resorption and triggers osteostimulative properties both in vivo and in vitro, as shown by increase in matrix formation. This study aimed to explore the efficacy of 1% ALN gel as local drug delivery (LDD) in adjunct to scaling and root planing (SRP) for the treatment of chronic periodontitis among smokers. Material and Methods 75 intrabony defects were treated in 46 male smokers either with 1% ALN gel or placebo gel. ALN gel was prepared by adding ALN into carbopol-distilled water mixture. Clinical parameters [modified sulcus bleeding index, plaque index, probing depth (PD), and periodontal attachment level (PAL)] were recorded at baseline, at 2 months, and at 6 months, while radiographic parameters were recorded at baseline and at 6 months. Defect fill at baseline and at 6 months was calculated on standardized radiographs by using the image analysis software. Results Mean PD reduction and mean PAL gain were found to be greater in the ALN group than in the placebo group, both at 2 and 6 months. Furthermore, a significantly greater mean percentage of bone fill was found in the ALN group (41.05±11.40%) compared to the placebo group (2.5±0.93%). Conclusions The results of this study showed 1% ALN stimulated a significant increase in PD reduction, PAL gain, and an improved bone fill compared to placebo gel in chronic periodontitis among smokers. Thus, 1% ALN, along with SRP, is effective in the treatment of chronic periodontitis in smokers.

Effects of periodontal treatment on primary sjȫgren's syndrome symptoms.

The aim of this longitudinal prospective study was to evaluate the effects of periodontal treatment on the clinical, microbiological and immunological periodontal parameters, and on the systemic activity (ESSDAI) and subjective (ESSPRI) indexes in patients with primary Sjögren's Syndrome (pSS). Twenty-eight female patients were divided into four groups: pSS patients with or without chronic periodontitis (SCP, SC, respectively), and systemically healthy patients with or without chronic periodontitis (CP, C, respectively). Periodontal clinical examination and immunological and microbiological sample collection were performed at baseline, 30 and 90 days after nonsurgical periodontal treatment (NSPT). Levels of interleukin IL-1ß, IL-8 and IL-10 in saliva and gingival crevicular fluid (GCF) were evaluated by ELISA, as well as the expression of Porphyromonas gingivalis (Pg), Aggregatibacter actinomycetemcomitans, (Aa) Tannerella forsythia (Tf), and Treponema denticola (Td), by qPCR. Systemic activity and pSS symptoms were evaluated by ESSDAI and ESSPRI. NSPT resulted in improved periodontal clinical parameters in both SCP and CP groups (p>0.05). Pg, Aa, and Tf levels decreased after NSPT only in CP patients (p<0.05). Significantly greater levels of IL-10 in GCF were verified in both SCP and CP groups (p<0.05). SCP patients showed increased salivary flow rates and decreased ESSPRI scores after NSPT. In conclusion, NSPT in pSS patients resulted in improved clinical and immunological parameters, with no significant effects on microbiological status. pSS patients also showed increased salivary flow and lower ESSPRI scores after therapy. Therefore, it can be suggested that NSPT may improve the quality of life of pSS patients.

Effects of periodontal treatment on primary sjogren's syndrome symptoms

Abstract The aim of this longitudinal prospective study was to evaluate the effects of periodontal treatment on the clinical, microbiological and immunological periodontal parameters, and on the systemic activity (ESSDAI) and subjective (ESSPRI) indexes in patients with primary Sjögren’s Syndrome (pSS). Twenty-eight female patients were divided into four groups: pSS patients with or without chronic periodontitis (SCP, SC, respectively), and systemically healthy patients with or without chronic periodontitis (CP, C, respectively). Periodontal clinical examination and immunological and microbiological sample collection were performed at baseline, 30 and 90 days after nonsurgical periodontal treatment (NSPT). Levels of interleukin IL-1β, IL-8 and IL-10 in saliva and gingival crevicular fluid (GCF) were evaluated by ELISA, as well as the expression of Porphyromonas gingivalis (Pg), Aggregatibacter actinomycetemcomitans, (Aa) Tannerella forsythia (Tf), and Treponema denticola (Td), by qPCR. Systemic activity and pSS symptoms were evaluated by ESSDAI and ESSPRI. NSPT resulted in improved periodontal clinical parameters in both SCP and CP groups (p>0.05). Pg, Aa, and Tf levels decreased after NSPT only in CP patients (p<0.05). Significantly greater levels of IL-10 in GCF were verified in both SCP and CP groups (p<0.05). SCP patients showed increased salivary flow rates and decreased ESSPRI scores after NSPT. In conclusion, NSPT in pSS patients resulted in improved clinical and immunological parameters, with no significant effects on microbiological status. pSS patients also showed increased salivary flow and lower ESSPRI scores after therapy. Therefore, it can be suggested that NSPT may improve the quality of life of pSS patients.

Gingival crevicular fluid oxidative stress level in patients with periodontal disease and hyperlipidemia

Abstract: This study aimed to assess the impact of hyperlipidemia on healthy and diseased periodontal tissue by evaluating oxidative stress biomarkers in gingival crevicular fluid (GCF). Clinical periodontal parameters and blood serum lipid, GCF malondialdehyde (MDA), protein carbonyl (PC), and total antioxidant capacity (TAOC) levels were evaluated in six age and sex-matched groups (n = 15 each) of normolipidemic and hyperlipidemic individuals as follows: normolipidemic + periodontally healthy (H), normolipidemic + gingivitis (G), normolipidemic + chronic periodontitis (CP), hyperlipidemic + periodontally healthy (HH), hyperlipidemic + gingivitis (HG), and hyperlipidemic + CP (HCP). GCF MDA, and PC levels varied among groups, with patients with periodontitis having the highest MDA and PC levels [CP > G > H (p < 0.01) and HCP > HG > HH (p < 0.01)] and the lowest TAOC levels [CP < G < H (p < 0.01) and HCP < HG < HH (p < 0.01)]. Furthermore, paired comparisons showed MDA and PC levels to be higher and TAOC levels to be lower in HCP compared with NCP (p < 0.01). In patients with hyperlipidemia, GCF, MDA, and PC levels positively correlated with clinical assessments and serum triglycerides (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL) levels and negatively correlated with serum high-density lipoprotein cholesterol (HDL) levels, whereas GCF TAOC levels negatively correlated with clinical assessments and serum TG, TC, and LDL levels, but positively correlated with serum HDL levels (p < 0.01). In normolipidemic patients, GCF, MDA, and PC levels positively correlated with clinical assessments and serum TG levels and negatively correlated with serum HDL levels, whereas GCF TAOC levels negatively correlated with clinical assessments and serum TG levels and positively correlated with serum HDL levels (p < 0.01). In conclusion, abnormal serum lipid subfractions could be considered a risk factor for enhancing oxidative stress in GCF in the presence of periodontal disease.

Predictors of smoking cessation in smokers with chronic periodontitis: a 24-month study.

The purpose of this 24-month study was to identify predictors of smoking cessation in a cohort of smokers with chronic periodontitis, attending a multidisciplinary smoking cessation program. Of the 286 subjects screened, 116 were included and received non-surgical periodontal treatment and smoking cessation therapy, which consisted of lectures, cognitive behavioral therapy, and pharmacotherapy, according to their individual needs. During initial periodontal treatment, dentists actively motivated the study subjects to stop smoking, using motivational interviewing techniques. Further smoking cessation counseling and support were also provided by the dentists, during periodontal maintenance sessions at 3, 6, 12 and 24 months of follow-up. Smoking status was assessed by means of a structured questionnaire, and was validated by exhaled carbon monoxide (CO) measurements. The Fagerström Test for Cigarette Dependence was used to assess smoking dependence. Of the 61 individuals that remained up to the 24-month examination, 31, 21 and 18 declared that they were not smoking at 3, 12 and 24 months, respectively. Smoking cessation after 24 months was associated with the male gender (OR = 3.77, 95%CI = 1.16-12.30), baseline CO levels less than 10ppm (OR = 5.81, 95%CI 1.76-19.23), not living or working with another smoker (OR = 7.38, 95%CI 1.76-30.98) and a lower mean Fagerström test score (OR = 5.63, 95%CI 1.55-20.43). We concluded that smoking cessation was associated with demographic, smoking history and cigarette dependence variables.

Predictors of smoking cessation in smokers with chronic periodontitis: a 24-month study

Abstract The purpose of this 24-month study was to identify predictors of smoking cessation in a cohort of smokers with chronic periodontitis, attending a multidisciplinary smoking cessation program. Of the 286 subjects screened, 116 were included and received non-surgical periodontal treatment and smoking cessation therapy, which consisted of lectures, cognitive behavioral therapy, and pharmacotherapy, according to their individual needs. During initial periodontal treatment, dentists actively motivated the study subjects to stop smoking, using motivational interviewing techniques. Further smoking cessation counseling and support were also provided by the dentists, during periodontal maintenance sessions at 3, 6, 12 and 24 months of follow-up. Smoking status was assessed by means of a structured questionnaire, and was validated by exhaled carbon monoxide (CO) measurements. The Fagerström Test for Cigarette Dependence was used to assess smoking dependence. Of the 61 individuals that remained up to the 24-month examination, 31, 21 and 18 declared that they were not smoking at 3, 12 and 24 months, respectively. Smoking cessation after 24 months was associated with the male gender (OR = 3.77, 95%CI = 1.16-12.30), baseline CO levels less than 10ppm (OR = 5.81, 95%CI 1.76-19.23), not living or working with another smoker (OR = 7.38, 95%CI 1.76-30.98) and a lower mean Fagerström test score (OR = 5.63, 95%CI 1.55-20.43). We concluded that smoking cessation was associated with demographic, smoking history and cigarette dependence variables.

Recolonização do biofilme supragengival e seus efeitos no biofilme subgengival em indivíduos com periodontite crônica / Recolonization of the supragingival biofilm and its effects on the subgingival biofilm in individuals with chronic periodontitis

A presença do biofilme dentário patogênico é o fator etiológico primário das doenças periodontais. Estudos demonstram diferenças na sucessão microbiana durante a formação desse biofilme periodontal entre indivíduos saudáveis e com periodontite. O objetivo desse estudo foi analisar a recolonização de espécies orais no biofilme dentário supragengival, bem como as alterações na composição do biofilme subgengival decorrentes do acúmulo do biofilme supragengival ao longo de 7 dias de ausência de higiene oral em indivíduos com saúde (SP) e periodontite crônica (PC). O exame clínico periodontal completo foi realizado em ambos os grupos (SP=15 e PC=15) por um examinador calibrado no início do estudo (-T1). Em seguida (T0), foi realizada a profilaxia profissional e os pacientes suspenderam todas as medidas de higiene oral durante 7 dias. Durante esse período, foram coletadas 4 amostras de biofilme supra e subgengival de quadrantes dentais aleatoriamente selecionados nos seguintes tempos: -T1 (antes da profilaxia), T0, T1 (2h após profilaxia), T2 (6h após profilaxia), T3 (24h após profilaxia) e T4 (7 dias após a profilaxia inicial). A técnica do "Checkerboard DNA-DNA hybridization" foi utilizada para avaliar a composição microbiana do biofilme supra e subgengival. Diferenças na recolonização microbiana entre grupos nos diferentes tempos e entre placa supra e subgengival foram determinadas pelos testes de Mann-Whitney, Friedman, GLM e Wilcoxon. Todos os indivíduos desenvolveram gengivite ao final dos 7 dias. Foram observadas poucas diferenças significativas na recolonização do biofilme supra e subgengival entre os grupos PC e SP. Não houve diferença na prevalência das espécies ao longo do tempo entre os grupos. As espécies N. mucosa e E.corrodens apresentaram uma diferença na cinética de colonização na placa supragengival e F. periodonticum na placa subgengival entre os grupos. Em termos de prevalência na placa subgengival, a maioria das espécies aumentou significativamente ao longo do tempo em ambos os grupos, com exceção de Aa, A. naeslundii, E. nodatum e P. gingivalis. Não houve diferenças nos níveis microbianos na placa supragengival entre os grupos. Na placa subgengival houve diferenças entre grupos em relação a alterações nos níveis bacterianos ao longo do tempo para as espécies T. denticola, N. mucosa e F. nucleatum ss vicentii. A recolonização do biofilme supragengival do grupo PC e SP foi semelhante durante a gengivite experimental de 7 dias. Entretanto, o aumento bacteriano ocorre de forma mais precoce no grupo SP comparado ao grupo PC. Ao longo do tempo, espécies patogênicas na placa subgengival, como: N. mucosa, T. denticola e Fusobacterium nucleatum ss. vicentii, diferiram significamente entre grupos, apresentando uma cinética de colonização diferente entre saúde e doença periodontal. A recolonização no biofilme subgengival sofreu pouca influência do biofilme supragengival(AU)

Pathogenic dental biofilm is the primary ethiological factor for periodontal diseases. Studies have shown differences in the microbial succession during the dental biofilm formation between periodontally healthy and periodontitis subjects. The purpose of the present investigation was to analyze the recolonization of oral species in supragingival dental plaque, as well as changes in the composition of subgingival biofilm resulting from the supragingival biofilm accumulation during seven days without oral hygiene in individuals with periodontal health (PH) and chronic periodontitis (CP). The clinical periodontal exam was performed in both groups (PH=15 e CP=15) by calibrated examiners at baseline (-T1). Immediately after prophylaxis (T0), all subjects received professional cleaning, and were asked to refrain from oral hygiene procedures for 7 days. Thus, 4 supra and subgingival plaque samples were collected from randomly selected quadrants at the following times: -T1 (before prophylaxis), T1 (after 2h prophylaxis), T2 (after 6h prophylaxis), T3 (after 24h prophylaxis) and T4 (7 days after the initial prophylaxis). The technique checkerboard DNA-DNA hybridization was used to evaluate the microbial composition of supra and subgingival. Differences in the microbial recolonization between groups at different times and among supra and subgingival plaque were determined using the Mann-Whitney test, Friedman, GLM and Wilcoxon. All subjects developed gingivitis at the end of 7 days period. Few significant differences were observed in the recolonization of supra and subgingival biofilm between the CP and PH groups. There was no difference in prevalence of species over time between CP and PH groups. There was no difference in the prevalence of species over time between groups. The species N. mucosa and E.corrodens showed a difference in colonization kinetics in supragingival plaque and F. periodonticum in subgingival plaque between groups. Regarding prevalence of species in subgingival plaque, most species increased significantly over time in both groups except Aa, A. naeslundii, E. nodatum and P. gingivalis. There was no difference in counts in supragingival plaque between groups. There were differences in subgingival plaque between groups regarding changes in bacterial counts of the species T. denticola, N. mucosa and F. nucleatum ss vicentii over time. Supragingival bacterial recolonization is similar between CP and PH in 7-days experimental gingivitis period. However, bacterial increase occurs earlier in SP than in PC. Along the observacional period, pathogenic species from subgingival plaque N. mucosa, T denticola and Fusobacterium nucleatum ss. vicentii, differed significantly between groups, showing a different kinetics between periodontal health and disease. The recolonization in subgingival biofilm suffered few influence of supragingival biofilm(AU)

Efeito do tratamento periodontal nos níveis de osteocalcina sérica em pacientes com diabetes tipo 2 e periodontite crônica severa / Effect of periodontal therapy on serum osteocalcin levels in patients with type 2 diabetes and severe chronic periodontitis

O tecido ósseo é metabolicamente ativo e sofre um processo contínuo de renovação e remodelação. A osteocalcina é um peptídeo secretado pelos osteoblastos. Apesar de ser primariamente depositada na matriz óssea recém-formada, uma pequena fração entra em circulação na corrente sanguínea, sendo considerada como um marcador de formação óssea e interferir na homeostasia da glicose. O objetivo deste estudo foi investigar se o tratamento periodontal afeta os níveis séricos de osteocalcina em pacientes com DM2 e periodontite crônica severa. 26 pacientes foram divididos em grupo teste (n=13, idade média de 55,8 ± 8,4 anos, 9 homens e 4 mulheres) e controle. (n=13, idade média de 59,4± 8.4, 5 homens e 8 mulheres). O grupo teste recebeu tratamento periodontal e grupo controle nãorecebeu tratamento periodontal imediato. O exame periodontal incluiu medidas de IP (Índice de placa), SS (Sangramento à sondagem), PBS (Profundidade de bolsa à sondagem), NIC (Nível de inserção clínica). Exames laboratoriais incluíram HBA1c, glicemia estimada, glicose, triglicerídeo, colesterol total e frações. A concentração de osteocalcina sérica foi analisada pelo ELISA. O exame periodontal, exames laboratoriais e concentração de osteocalcina foram reavaliados 90 dias após. Os resultados mostraram que não houve alterações significativas nos parâmetros periodontais, exames laboratoriais, e níveis de osteocalcina 90 dias após o tratamento periodontal. Conclusão: o tratamento periodotnal não influenciou nos níveis séricos da osteocalcina em pacientes com diabetes melllitus tipo 2 e periodontite crônica severa.

Bone tissue is metabolically active and undergoes a continuous process of resorption and formation. Osteocalcin is a peptide secreted by osteoblasts. Although primarily deposited in newly formed bone matrix, a small fraction enters into circulation in the bloodstream and is considered as a marker of bone formation and interferes with glucose homeostasis. The aim of this study was to investigate whether periodontal treatment affects serum osteocalcin levels in patients with type 2 diabetes and severe chronic periodontitis. 26 patients were divided into test group (n = 13, mean age 55.8 ± 8.4 years, 9 men and 4 women) and control. (n = 13, mean age 59.4 ± 8.4, 5 men and 8 women). The test group received periodontal treatment and untreated control group. Periodontal examination included PI measures (plaque index), BOP (bleeding on probing), PPD (probing pocket depth), CAL (clinical attachment level). Laboratory tests included HbA1c, glucose, triglyceride, total cholesterol and fractions. The concentration of serum osteocalcin was analyzed by ELISA. Periodontal examination, laboratory tests and concentration of osteocalcin were reassessed after 90 days. The results showed no significant changes in periodontal parameters, laboratory tests, and osteocalcin levels 90 days after periodontal treatment. In conclusion, periodontal treatment did not influence the serum levels of osteocalcin in patients with type 2 diabetes and severe chronic periodontitis.

Proteína C reactiva en pacientes con periodontitis crónica / C-reactive protein in patients with chronic periodontitis

La Periodontitis Crónica surge en las últimas décadas como un posible factor de riesgo para el desarrollo de eventos cardiovasculares. Bajo estas premisas, nace un nuevo paradigma que orienta el logro de diagnósticos, formas de prevención, intervención temprana y estrategias en el tratamiento de la Periodontitis Crónica. La Proteína C Reactiva (PCR) ha resultado ser un marcador de inflamación sistémica asociado a la Enfermedad Arterial Coronaria y a la Periodontitis Crónica.Objetivo del estudio: Conocer los niveles de Proteína C Reactiva en pacientes con Periodontitis Crónica Material y métodos: Se seleccionaron 80 pacientes del Postgrado de Periodoncia de la Facultad de Odontología de la Universidad Central de Venezuela. El estudio fue de tipo descriptivo, observacional, prospectivo. La data fue migrada a SPSS 17.0, para el análisis estadístico. Para las variables cuantitativas se utilizó la media y la desviación standart. Para evaluar la correlación entre variables se utilizó el coeficiente de correlación de Pearson, la prueba de Chi cuadrado de independencia y el análisis de Varianza para un solo factor. Resultados: De la muestra poblacional, El nivel sérico de Proteína C Reactiva ultrasensible resultó Factor de Riesgo Cardiovascular en 47 pacientes (58,8 por ciento). Discusión y conclusiones: No existe asociación entre los niveles de la Proteína C Reactiva ultrasensible y la presencia de Periodontitis Crónica generalizada.

Microbiological effects of periodontal therapy plus azithromycin in patients with diabetes: results from a randomized clinical trial

Evidencia actual sugiere que la infección periodontal puede agravar el control de la diabetes. El objetivo de este estudiofue determinar los cambios en la frecuencia de detección de porphyromonas gingivalis, Tannerella forsythia, Treponema denticola y Aggregatibacter actinomycetemcomitans en pacientes con diabetes con el uso de terapia mecánica no quirúrgica mas azitromicina en un estudio clínico controlado aleatorizado.Ciento cinco pacientes (105) con diabetes y perio -dontitis fueron asignados aleatoriamente en tres grupos: terapiamecánica mas azitromicina, terapia mecánica mas placebo y profilaxis supragingival mas azitromicina. Un análisis periodontal completo y detección de patógenos perio dontales por medio de reacción en cadena de la polimerasa (PCR) se realizaron al inicio, 3, 6 y 9 meses después de la terapia pe -riodontal. La frecuencia de detección de Porphyromonas gingivalis, Treponema denticola y Aggregatibacter actinomycetemcomitans disminuyó a los 3 meses en todos los grupos. La frecuencia de detección de Tannerella forsythia se incrementó a los 3 meses en todos los grupos. Todos los patógenosperiodontales mostraron una frecuencia de detección similar a los 9 meses en todos los grupos. La terapia periodontal mas azitromicina no tuvo efectos adicionales sobre la frecuencia dedetección de los patógenos periodontales investigados en pacientes diabéticos...

Serum leveis of inflammatory markers in type 2 diabetes patients with chronic periodontitis

Diabetes has been associated with periodontitis, but the mechanisms through which periodontal diseases affect the metabolic control remain unclear. Objective: This study aimed to evaluate serum leveis of inflammatory markers, IL-8, IL-6 and monocyte chemoattractant protein 1 (MCP-1), in type 2 diabetic patients in the presence of chronic periodontitis. Material and Methods: Forty two individuals were enrolled in this study and assigned to one of five groups: diabetes mellitus with inadequate glycemic control and periodontitis (DMI+P, n = 10), diabetes mellitus with adequate glycemic control and periodontitis (DMA+P, n = 10), diabetes mellitus without periodontitis (DM, n = 10), periodontitis without diabetes (P, n=6), and neither diabetes nor periodontitis (H, n = 6). Periodontal clinical examination included visible plaque index (PL), gingival bleeding index (GB), probing depth (PD), attachment level (AL) and bleeding on probing (BP). Glycemic control was evaluated by serum concentration of glycated hemoglobin (HbAlc). Inflammatory serum markers IL-8, IL-6 and (MCP-1) were measured by ELISA. Results: DMI+P and DMA+P groups presented higher PD (p=0.025) and AL (p=0.003) values when compared to the P group. There were no significant differences among groups for IL-6, IL-8 and MCP-1 serum levels. Conclusions: Although periodontitis was more severe in diabetic patients, the serum levels of the investigated inflammatory markers did not differ among the groups. .

Serum levels of inflammatory markers in type 2 diabetes patients with chronic periodontitis.

UNLABELLED: Diabetes has been associated with periodontitis, but the mechanisms through which periodontal diseases affect the metabolic control remain unclear. OBJECTIVE: This study aimed to evaluate serum leveis of inflammatory markers, IL-8, IL-6 and monocyte chemoattractant protein 1 (MCP-1), in type 2 diabetic patients in the presence of chronic periodontitis. MATERIAL AND METHODS: Forty two individuals were enrolled in this study and assigned to one of five groups: diabetes mellitus with inadequate glycemic control and periodontitis (DMI+P, n = 10), diabetes mellitus with adequate glycemic control and periodontitis (DMA+P, n = 10), diabetes mellitus without periodontitis (DM, n = 10), periodontitis without diabetes (P, n=6), and neither diabetes nor periodontitis (H, n = 6). Periodontal clinical examination included visible plaque index (PL), gingival bleeding index (GB), probing depth (PD), attachment level (AL) and bleeding on probing (BP). Glycemic control was evaluated by serum concentration of glycated hemoglobin (HbAlc). Inflammatory serum markers IL-8, IL-6 and (MCP-1) were measured by ELISA. RESULTS: DMI+P and DMA+P groups presented higher PD (p=0.025) and AL (p=0.003) values when compared to the P group. There were no significant differences among groups for IL-6, IL-8 and MCP-1 serum levels. CONCLUSIONS: Although periodontitis was more severe in diabetic patients, the serum levels of the investigated inflammatory markers did not differ among the groups.

Factores de riesgo y periimplantitis en la terapia implantológica: revisión narrativa / Risk factors and periimplantitis in implant therapy: narrative review

Las enfermedades que involucran a los tejidos que rodean a los dientes y a los implantes osteointegrados son el resultado de una interacción entre algún tipo de agente patológico (bacteriano, viral, etc.) y la respuesta inmunitaria del huésped. Estas interacciones se pueden dar tanto en los tejidos dentarios como en aquellos biomateriales que se introducen para tratar de corregir algún tipo de patología periodontal; los implantes al ser sustitutos biocompatibles de las piezas dentarias no están exentas de este tipo de interacciones que muchas veces cursan con patologías periodontales y periimplantarias. La periimplantitis es un tipo de patología que resulta de dicha interacción; los factores de riesgo e indicadores de riesgo de la periimplantitis son amplios y complejos. El presente artículo resume las múltiples fuentes de información de la literatura científica para abordar al detalle los aspectos de los principales factores de riesgo y la periimplantitis en la terapia implantológica.

Diseases involving tissue around the teeth and osseo integrated implants are the result of an interaction between some type of pathological agent (bacterial, viral, etc.) and host immune response. These interactions can occur both in the dental tissues as those biomaterials which are introduced to attempt to correct some type of periodontal disease, the implant being a biocompatible substitute of the teeth is not free from this type of interaction often enrolled periodontal and peri-implant pathology. The peri-implantitisis a type of disease that results from this interaction, the risk factors and risk indicators of peri-implantitis are broad and complex. This article summarizes the multiple sources of information in the scientific literature to address in detail the aspects of the main risk factors and the peri-implantitis in the peri implant therapy.